{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:46:36Z","timestamp":1785897996823,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["25H00270"],"award-info":[{"award-number":["25H00270"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jiac.2026.103010","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:11:00Z","timestamp":1781136660000},"page":"103010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of body composition on initial teicoplanin dosing and optimization of the regimen"],"prefix":"10.1016","volume":"32","author":[{"given":"Shoji","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-1896","authenticated-orcid":false,"given":"Kazutaka","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Jono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103010_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkab499","article-title":"Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"77","author":"Hanai","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jiac.2016.01.019","article-title":"Retrospective study of teicoplanin loading regimen that rapidly achieves target 15\u201330 \u03bcg\/mL serum trough concentration","volume":"22","author":"Kato","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199018030-00002","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"18","author":"Rowland","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103010_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"39","author":"Wilson","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103010_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkg147","article-title":"Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose","volume":"51","author":"Pea","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib6","first-page":"8","article-title":"Clinical efficacy of high treatment with teicoplanin (TEIC) against MRSA infections and trough concentration of TEIC","volume":"55","author":"Ueda","year":"2007","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jiac.2015.02.002","article-title":"Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections","volume":"21","author":"Nakamura","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40360-020-00424-3","article-title":"Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 \u03bcg\/mL using a regimen of 12 mg\/kg for five doses within the initial 3 days","volume":"21","author":"Ueda","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jiac.2026.103010_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/phar.2769","article-title":"Comprehensive guidance for antibiotic dosing in obese adults: 2022 update","volume":"43","author":"Meng","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2026.103010_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1467-789X.2008.00546.x","article-title":"Effect of body mass index on the outcome of infections: a systematic review","volume":"10","author":"Falagas","year":"2009","journal-title":"Obes Rev"},{"key":"10.1016\/j.jiac.2026.103010_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pds.3461","article-title":"The effect of obesity on antibiotic treatment failure: a historical cohort study","volume":"22","author":"Longo","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jiac.2026.103010_bib12","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/cid\/ciac322","article-title":"Low body mass index at treatment initiation and rifampicin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis","volume":"75","author":"Campbell","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103010_bib13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1017\/ash.2024.441","article-title":"Evaluation of prescribing practices and treatment failure for purulent skin and soft tissue infections in patients with obesity","volume":"5","author":"Miller","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.jiac.2026.103010_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.11.014","article-title":"Teicoplanin 24-h loading dose regimen using a decision tree model to target serum trough concentration of 15-30 \u03bcg\/mL: a retrospective study","volume":"31","author":"Kondo","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01059273","article-title":"Pharmacokinetics of teicoplanin in man after intravenous administration","volume":"12","author":"Traina","year":"1984","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.jiac.2026.103010_bib16","first-page":"650","article-title":"Gentamicin therapy","volume":"8","author":"Devine","year":"1974","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jiac.2026.103010_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103010_bib18","first-page":"1","article-title":"Population pharmacokinetics of teicoplanin in adult patients","volume":"54","author":"Nakayama","year":"2006","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1620\/tjem.221.29","article-title":"Low body mass index and low serum albumin are predictive factors for short-term mortality in elderly Japanese requiring home care","volume":"221","author":"Kitamura","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jiac.2026.103010_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dkx473","article-title":"Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy","volume":"73","author":"Byrne","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FTD.0b013e3180690755","article-title":"Variability in teicoplanin protein binding and its prediction using serum albumin concentrations","volume":"29","author":"Yano","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2026.103010_bib22","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfh983","article-title":"Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example","volume":"20","author":"Delanaye","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jiac.2026.103010_bib23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/jcsm.12969","article-title":"Muscle mass and estimates of renal function: a longitudinal cohort study","volume":"13","author":"Groothof","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jiac.2026.103010_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01719-23","article-title":"Updated antimicrobial dosing recommendations for obese patients","volume":"68","author":"Castro-Balado","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103010_bib25","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S1473-3099(25)00155-0","article-title":"The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments","volume":"25","author":"M\u00e4rtson","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.103010_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijantimicag.2016.01.009","article-title":"Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review","volume":"47","author":"Alobaid","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.103010_bib27","series-title":"WHO technical report Series No. 894","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","year":"2000"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:07:42Z","timestamp":1785895662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2600108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1341321X2600108X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of body composition on initial teicoplanin dosing and optimization of the regimen","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103010"}}